YHB Investment Advisors Inc. raised its holdings in CME Group Inc (NASDAQ:CME) by 10.5% during the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 30,557 shares of the financial services provider’s stock after purchasing an additional 2,894 shares during the quarter. YHB Investment Advisors Inc.’s holdings in CME Group were worth $5,748,000 as of its most recent filing with the Securities & Exchange Commission.
Other large investors have also added to or reduced their stakes in the company. BP PLC grew its position in CME Group by 2.2% during the third quarter. BP PLC now owns 102,200 shares of the financial services provider’s stock worth $17,396,000 after buying an additional 2,200 shares in the last quarter. Steward Partners Investment Advisory LLC grew its position in CME Group by 42.8% during the third quarter. Steward Partners Investment Advisory LLC now owns 16,471 shares of the financial services provider’s stock worth $2,804,000 after buying an additional 4,939 shares in the last quarter. Nisa Investment Advisors LLC grew its position in CME Group by 13.4% during the third quarter. Nisa Investment Advisors LLC now owns 122,863 shares of the financial services provider’s stock worth $20,912,000 after buying an additional 14,534 shares in the last quarter. Chartwell Investment Partners LLC boosted its holdings in shares of CME Group by 60.3% in the 3rd quarter. Chartwell Investment Partners LLC now owns 39,284 shares of the financial services provider’s stock valued at $6,687,000 after purchasing an additional 14,770 shares in the last quarter. Finally, Pittenger & Anderson Inc. boosted its holdings in shares of CME Group by 1.3% in the 3rd quarter. Pittenger & Anderson Inc. now owns 61,396 shares of the financial services provider’s stock valued at $10,450,000 after purchasing an additional 790 shares in the last quarter. Hedge funds and other institutional investors own 85.73% of the company’s stock.
A number of brokerages have recently commented on CME. Citigroup began coverage on CME Group in a research note on Tuesday, November 20th. They issued a “buy” rating and a $220.00 price target for the company. Berenberg Bank upgraded CME Group from a “hold” rating to a “buy” rating and set a $220.00 price target for the company in a research note on Tuesday, November 20th. Atlantic Securities began coverage on CME Group in a research note on Wednesday, November 28th. They issued a “neutral” rating and a $200.00 price target for the company. UBS Group cut CME Group from a “buy” rating to a “neutral” rating and increased their price target for the company from $185.00 to $204.00 in a research note on Wednesday, November 28th. Finally, Deutsche Bank increased their price target on CME Group from $205.00 to $206.00 and gave the company a “buy” rating in a research note on Friday, November 16th. Eight research analysts have rated the stock with a hold rating and ten have assigned a buy rating to the stock. The company presently has a consensus rating of “Buy” and a consensus target price of $193.00.
CME Group (NASDAQ:CME) last posted its quarterly earnings data on Thursday, October 25th. The financial services provider reported $1.45 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $1.42 by $0.03. CME Group had a return on equity of 9.18% and a net margin of 113.67%. The firm had revenue of $904.20 million during the quarter, compared to analyst estimates of $910.50 million. On average, analysts forecast that CME Group Inc will post 6.69 earnings per share for the current year.
The company also recently announced a dividend, which will be paid on Wednesday, January 16th. Stockholders of record on Friday, December 28th will be paid a $1.75 dividend. The ex-dividend date is Thursday, December 27th. CME Group’s dividend payout ratio is presently 58.70%.
In other CME Group news, COO Julie Holzrichter sold 3,353 shares of CME Group stock in a transaction dated Tuesday, November 6th. The stock was sold at an average price of $186.71, for a total transaction of $626,038.63. Following the completion of the transaction, the chief operating officer now owns 45,627 shares in the company, valued at approximately $8,519,017.17. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Charles P. Carey sold 2,800 shares of CME Group stock in a transaction dated Friday, November 2nd. The shares were sold at an average price of $183.45, for a total value of $513,660.00. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 58,647 shares of company stock valued at $11,107,550. 0.43% of the stock is currently owned by company insiders.
ILLEGAL ACTIVITY WARNING: “CME Group Inc (CME) Shares Bought by YHB Investment Advisors Inc.” was published by Dakota Financial News and is owned by of Dakota Financial News. If you are accessing this news story on another website, it was copied illegally and republished in violation of U.S. & international copyright legislation. The original version of this news story can be accessed at https://dakotafinancialnews.com/2019/01/11/cme-group-inc-cme-shares-bought-by-yhb-investment-advisors-inc.html.
About CME Group
CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products, and metals.
Read More: How is a Moving Average Calculated?
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc (NASDAQ:CME).
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.